Font Size: a A A

Observing The Growth Of Pharmaceutical Listed Ebterprises By The Financial Statement Analysis

Posted on:2011-09-02Degree:MasterType:Thesis
Country:ChinaCandidate:Z Y LiFull Text:PDF
GTID:2189330332484412Subject:Business Administration
Abstract/Summary:PDF Full Text Request
Our country is currently developing capital market and the number of listed enterprises has increased in recent years. As the pharmaceutical industry is an important part of the national economy, the number of listed of enterprises has rapidly increased in the pharmaceutical industry with the development and expansion of the capital market. Although the pharmaceutical industry is a high degree of industry boom industry, and this sentiment will maintain in the future a very long period, but not all pharmaceutical enterprises can catch a ride with high industry boom. Public enterprises in the industry are still the good and the bad the in the industry. Many investors who believe in the value investment philosophy are concerned about how to judge the growth of listed enterprises. This paper uses the evaluation of corporate growth theories and research methods, combined with the analysis of corporate financial statements related to theory, the growth of pharmaceutical companies built the financial statements of analysis and evaluation system. This paper pulled many complex internal and external causes of the growth of listed companies, directly from the real data of enterprises growth——one of the financial statements, from the perspective of financial statement analysis to observe the listed enterprises growth. Financial statement analysis is introduced to distinguish the importance of enterprises growth, describing how to determine whether the financial statements mixed with "water", and the balance sheet, income statement, analysis of cash flow. Finally, listed seven financial indicators related growth and reasonable capital structure. By a summary of conclusions and better growth of financial performance:In a longer period (5 consecutive years) the company can maintain a high margin core business, net profit is mainly constituted by the loss of regular, net profit and the main profit and the synchronization with the sustained growth. And has continued revenue growth to support the main business, have sufficient cash flows for the security, moderately leveraged, has a good capital structure, and has relatively strong solvency. The financial performance of the company will improve the enterprises profitability continuously. And control the risk of companies effectively, so it has good growth. Finally, the paper also verified with an example of the accuracy of this view, practicality and maneuverability. This research papers on many small investors has certain directive application value.
Keywords/Search Tags:financial statement analysis, pharmaceutical listed enterprises, growth, case study
PDF Full Text Request
Related items